Venture Catalysts contributed Rs 2 crore to the pre-seed round of funding for healthtech startup Humors Tech.
The money raised will go toward expediting the commercial launch of the company’s flagship product, Respyr, as well as clinical validation research and international market expansion.
Respyr by Humors Tech, founded by Ankur Jaiswal and Suchita Kanaldekar, targets 50% of preventable deaths and offers a practical solution to the public health crisis.
Respyr offers consumers sophisticated health tracking by integrating with wearables and fitness applications. Based on screening results, it acts as a gateway to telemedicine platforms, connecting users with timely medical interventions.
A breath-based health screening tool called Respyr can identify and track serious lifestyle conditions such as diabetes, hypertension, heart, liver, kidney, and respiratory problems early on.
Corporates, insurers, government hospitals, remote healthcare facilities, and consumers are all served by Humors Tech’s dual B2B and B2B2C model. Additionally, Respyr provides flexible applications for insurance participation, employee health programs, quick medical screening, and remote healthcare access.
Starting with a serviceable available market (SAM) of 163 million health-conscious people, Humors Tech hopes to reach a total addressable market (TAM) of 612 million people in India.
